Vogt-koyanagi-harada syndrome in childhood

International Ophthalmology Clinics

Volumn 48, Issue 3, 2008, Pages 107-117

  García, Lourdes Arellanes ^a   Carroll, Mónica Orozco ^a   Leon, Manuel Alejandro Garza ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HLA DR ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ALOPECIA; CATARACT; CHILDHOOD DISEASE; CHOROIDITIS; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; GLAUCOMA; HUMAN; IRIDOCYCLITIS; MENINGISM; OCULAR FIBROSIS; OPTICAL COHERENCE TOMOGRAPHY; PLEOCYTOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RETINA DETACHMENT; REVIEW; SCLERITIS; TINNITUS; UNSPECIFIED SIDE EFFECT; VISUAL ACUITY; VITILIGO; VOGT KOYANAGI SYNDROME; ADOLESCENT; CHILD; MENINGOENCEPHALITIS; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 51649111763     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e31817d9b70     Document Type: Review

References (41)

1. Inomata H. Vogt-Koyanagi-Harada disease. In: Yanoff M, Ducker JS, eds. Ophthalmology. 2nd ed. St. Louis: Mosby Inc; 2004:1196-1200.
2. Andreoli CM, Foster CS. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2006; 46: 111-122.
3. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995; 39:265-292.
4. Schenkl A. Ein Fall von plötzlich aufgetretener poliosis circunscripta der wimpern. Arch Dermatol Syph. 1783; 5:137-139.
5. Hutchinson J. A case of blanched eyelashes. Arch Surg. 1892; 4:357.
6. Vogt A. Fruhzeitiges Ergaruen der Zilien und Bemerkungen uber den sugenaten plotzilchen Eintreitt dieser Veranderung. Klin Monatsbl Augenheilkd. 1906; 44:228-242.
7. Koyanagi Y. Dysakusis, Alopecia und Poliosis bei schwerer uveitis nicht traumatischen Ursprugs. Klin Monatsbl Augenheilkd. 1929; 82:194-211.
8. Harada E. Acute diffuse choroiditis. Acta Soc Ophthalmol Jpn. 1926; 30:356-378.
9. Babel J. Syndrome de Vogt-Koyanagi (Uveite bilateral, poliosis, alopecie, vitiligo et dysacousie). Schweiz Med Wochenschr. 1932; 44:1136-1140.
10. Bruno MG, McPherson SD. Harada's disease. Am J Ophthalmol. 1949; 32:513-522.
11. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi- Harada disease: report of an International Committee on Nomenclature. Am J Ophthalmol. 2001; 131:647-652.
12. Kitamura M, Takami K, Kitachi N, et al. Comparative study of two sets of criteria for the diagnosis of Vogt- Koyanagi- Harada's disease. Am J Ophthalmol. 2005; 139: 1080-1085.
13. Read RW, Rao NA. Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis. Ocular Inmunol Inflamm. 2000; 8:227-234.
14. Read RW, Rao NA, Cunningham ET. Vogt-Koyanagi- Harada disease. Curr Ophthalmol. 2000; 11:437-442.
15. Read RW. Vogt-Koyanagi- Harada disease. Ophthalmol Clin North Am. 2002; 15:333-341.
16. Wakabayashi T, Morimura Y, Miyamoto Y, et al. Changing patterns of intraocular inflammatory disease in Japan. Ocul Inmunol Inflamm. 2003; 11:277-286.
17. Belfort R Jr, Nishi M, Hayashi S, et al. Vogt-Koyanagi-Harada's disease in Brazil. Jpn J Ophthalmol. 1988; 32:344-347.
18. Mondkar SV, Biwas J, Ganesh SK. Analysis of 87 cases with Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2000; 44:296-301.
19. Tabbara KF, Chavis P, Freeman W. Vogt-Koyanagi- Harada syndrome in children compared to adults. Acta Ophthal Scand. 1998; 76:723-726.
20. Rathinam SR, Vijayalakshmi P, Cunningham E, et al. Vogt-Koyanagi-Harada syndrome in children. Ocular Immunol Inflamm. 1998; 6:155-161.
21. Abu El-Asrar AM, Al-Kharashi AS, Aldibni H, et al. Vogt-Koyanagi-Harada disease in children. Eye. 2007; 4:1-8.
22. Kanski JJ, Shun-Shin GA. Systemic uveitis syndromes in childhood: an analysis of 340 cases. Ophthalmology. 1984; 91:1247-1252.
23. Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol. 1988; 32:334-343.
24. Lucena DR, Paula JS, Silva GC, et al. Incomplete Vogt-Koyanagi-Harada syndrome associated with HLA DRB1*01 in a 4-year-old child: case report. Arq Bras Oftalmol. 2007; 70:340-342.
25. Cunningham ET, Demetrius R, Frieden I, et al. Vogt-Koyanagi-Harada syndrome in a 4-year-old child. Am J Ophthalmol. 1995; 120:675-677.
26. Rajendram R, Evans M, Rao NA. Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2005; 45:115-134.
27. Yamaki K, Goto K, Kayawaka K, et al. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease.J Immunol. 2000; 165:7323-7329.
28. Alaez C, del Pilar Mora M, Arellanes L, et al. Strong association of HLA class II sequence in Mexicans with Vogt-Koyanagi- Harada's disease. Hum Immunol. 1999; 60:875-882.
29. Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin. 1990; 30:279-285.
30. Liu Q, Zhang M, Qiu C, et al. Association of HLA-DQA1 and DQB1 alleles with Vogt- Koyanagi-Harada syndrome in Han Chinese population. Zhonghua Yan Ke Za Zhi. 1999; 35:210-215.
31. Kim MH, Seong MC, Kwak NH, et al. Association of HLA with Vogt-Koyanagi- Harada syndrome in Koreans. Am J Ophthalmol. 2000; 129:173-177.
32. Goldberg AC, Yamamoto JH, ChiarellaJM, et al. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol. 1998; 59:183-188.
33. Gupta A, Kamal S, Gupta V, et al. HLA typing in Vogt-Koyanagi- Harada syndrome in North Indian patients. Ocul Immunol Inflamm. 2007; 15:89-97.
34. Friedman AH, Deutsh-Sokol RH. Sugiura's sign. Perilimbal vitiligo in the Vogt- Koyanagi-Harada syndrome. Ophthalmology. 1981; 88:1159-1165.
35. Arellanes L, Hernandez M, Fromow J, et al. Fluorescein fundus angiography findings in Vogt-Koyanagi- Harada syndrome. Int Ophthalmol. 2007; 27:155-161.
36. Maruyama Y, Kishi S. Tomographic features of serous retinal detachment in Vogt- Koyanagi- Harada syndrome. Ophthalmic Surg Lasers Imaging. 2004; 35:239-242.
37. Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology. 2001; 108:54-64.
38. Wada S, Kohno T, Yanagihara N, et al. Ultrasound biomicroscopic study of ciliary body changes in the post-treatment phase of Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2002; 86:1374-1379.
39. Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005; 20:183-190.
40. Soheilian M, Aletaha M, Yazdani S, et al. Management of paediatric Vogt-Koyanagi- Harada (VKH)-associated panuveítis. Ocular Immunol Inflamm. 2006; 14:91-98.
41. Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi- Harada patients as first-line therapy. Ocular Immunol Inflamm. 2006; 14:87-90.